DB
Therapeutic Areas
Relay Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RLY-4008 | FGFR2-altered solid tumors (e.g., cholangiocarcinoma) | Phase 1/2 |
| RLY-2608 | Advanced breast cancer and other solid tumors with PIK3CA mutations | Phase 1 |
| RLY-5836 | Undisclosed precision oncology target | Preclinical |
| GDC-1971 (formerly RLY-1971) | Undisclosed | Phase 1 |